Pancreatic Exocrine Insufficiency Is Not Uncommon in Celiac Disease: A Systematic Review and Meta‐Analysis
Authors:
- Miroslav VujasinovicMVMiroslav Vujasinovic
- Nina BlazevicNBNina Blazevic
- Patrick MaisonneuvePMPatrick Maisonneuve
- Anders ForssAFAnders Forss
- Nikola PanicNPNikola Panic
- Nina BlochNBNina Bloch
- J. Enrique Dominguez MunozJMJ. Enrique Dominguez Munoz
- Jonas F. LudvigssonJLJonas F. Ludvigsson
- J.‐Matthias LöhrJLJ.‐Matthias Löhr
Open Access
- 9 July 2025
- journal article
- review article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 13 (7) , 1107-1115
Abstract
Introduction: Pancreatic exocrine insufficiency (PEI) is seen in primary pancreatic disease but has also been seen in extrapancreatic conditions including celiac disease (CeD). The symptoms of PEI and CeD often overlap, which makes diagnostics challenging. In this systematic review and meta‐analysis, we aimed to investigate the prevalence of PEI in CeD. Methods: With the assistance of a professional librarian, we searched five databases: PubMed, Embase, Cochrane, Web of Science Core Collection, and Google Scholar, up until October 21, 2024. The pooled prevalence of PEI in biopsy‐confirmed CeD was estimated, and the quality of studies appraised. Results: We identified and screened the titles and abstracts of 1432 publications, of which 60 were reviewed in full text and 12 were included in the analyses. The overall pooled weighted prevalence of PEI in CeD was 13.5% (95% CI 7.2–21.0). The prevalence was similar among children (14.2%; 95% CI 2.0–32.8) and adults (12.8%; 95% CI 7.8–18.7) with CeD. The prevalence in studies that used secretory testing to define PEI was 13.1% (95% CI 6.4–21.3) and in those requiring digestive tests 17.1% (95% CI 5.8–32.1). The weighted prevalence of PEI was significantly higher among untreated CeD patients (18.2%) than patients on a gluten‐free diet (6.9%) ( p = 0.03), in both adults and children. Conclusion: One in eight individuals with CeD may suffer from PEI. The prevalence was particularly high in untreated CeD. PEI should be considered in patients who do not respond to a gluten‐free diet.Keywords
This publication has 34 references indexed in Scilit:
- European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020Journal of Pediatric Gastroenterology and Nutrition, 2020
- Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic SurgeryAnnals of Surgery, 2016
- Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence dataJBI Evidence Implementation, 2015
- Patients With Celiac Disease Have an Increased Risk for PancreatitisClinical Gastroenterology and Hepatology, 2012
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- Subclinical Exocrine Pancreatic Dysfunction Resulting From Decreased Cholecystokinin Secretion in the Presence of Intestinal Villous AtrophyJournal of Pediatric Gastroenterology and Nutrition, 2006
- Basal and Fat-Stimulated Plasma Peptide YY Levels in Celiac DiseaseDigestive Diseases and Sciences, 2001
- Diagnostic Accuracy of Fecal Elastase 1 Assay in Patients with Pancreatic Maldigestion or Intestinal MalabsorptionDigestive Diseases and Sciences, 2001
- The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free dietGastroenterology, 1997
- Pancreatic enzyme therapy in childhood celiac diseaseDigestive Diseases and Sciences, 1995